Ship Healthcare Holdings (3360) AI Stock Analysis

• Market Cap: ¥221.62B
• Dividend Yield: 2.19%
• Average Volume (3M): 255.53K
• Price to Earnings (P/E): 16.0
• Beta (1Y): 0.51
• Revenue Growth: 8.90%
• EPS Growth: -3.71%
• Country: JP
• Employees: 7,793
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 36.46
• Shares Outstanding: 94,350,136
• 10 Day Avg. Volume: 330,690
• 30 Day Avg. Volume: 255,526
• PEG Ratio: 1.29
• Price to Book (P/B): 1.27
• Price to Sales (P/S): 0.28
• P/FCF Ratio: 11.42
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥2,983.33
• Price Target Upside: 11.71% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 3
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 75 Outperform
• Price Target: ¥2,971.00 ▲(11.25% Upside)

Ship Healthcare Holdings scores well due to its strong financial performance and bullish technical indicators. The company's consistent revenue growth and financial stability are significant strengths. However, the stock's valuation is fair, and technical indicators suggest it may be nearing overbought levels, which could limit short-term upside.

Positive Factors

Revenue Growth

Consistent revenue growth indicates strong market demand and effective business strategies, enhancing the company's competitive position in the healthcare sector.

Financial Stability

Reduced leverage and a strong equity position enhance financial stability, providing the company with greater flexibility to invest in growth opportunities.

Cash Flow Management

Effective cash flow management ensures the company can sustain operations and fund strategic initiatives, contributing to long-term financial health.

Negative Factors

Cash Reserves

Decreasing cash reserves could limit the company's ability to quickly respond to unforeseen expenses or investment opportunities, potentially impacting liquidity.

Profit Margin Pressure

While margins have improved, maintaining profitability in a competitive industry may be challenging, potentially impacting future earnings if cost pressures rise.

Debt Monitoring

Despite reduced leverage, the presence of debt requires careful management to ensure it does not become a burden, especially in changing economic conditions.

Ship Healthcare Holdings Business Overview & Revenue Model

Company Description

Ship Healthcare Holdings, Inc. engages in the medical, healthcare, welfare, and nursing care businesses worldwide. It operates through four segments: Total Pack Produce Business, Medical Supply Business, Lifecare Business, and Dispensing Pharmacy Business. The Total Pack Produce segment engages in sale of medical devices and medical equipment based on bulk orders; offers consulting services on medicine, healthcare, welfare, and nursing care facilities; and leasing of real estate to medical facilities and other tenants. The Medical Supply segment sells medical examination and treatment materials, and special treatment materials. The Life Care segment operates homes for senior citizens, group homes, and other facilities and nutritional services. The Dispensing Pharmacy segment operates dispensing pharmacies. The company was incorporated in 1992 and is headquartered in Suita, Japan.

How the Company Makes Money

Ship Healthcare Holdings generates revenue primarily through the sale and distribution of medical supplies and equipment to hospitals, clinics, and healthcare providers. The company operates on a B2B model, where it partners with manufacturers and suppliers to offer a wide array of products, including surgical instruments, diagnostic equipment, and home healthcare products. Key revenue streams include direct sales of medical products, logistics and supply chain management services, and value-added services such as equipment maintenance and training. Strategic partnerships with healthcare institutions and suppliers enhance their distribution capabilities and market reach, contributing significantly to their earnings.

Ship Healthcare Holdings Financial Statement Overview

Summary

Ship Healthcare Holdings demonstrates robust financial performance with consistent revenue growth, strong profit margins, and effective cash flow management. The company's reduced leverage and improved return on equity enhance its financial stability, positioning it well for future growth.

Income Statement

Ship Healthcare Holdings has demonstrated robust revenue growth over the years, with a notable increase from 514.35 billion yen in 2022 to 678.23 billion yen in 2025. The gross profit margin remains stable at around 10%, and the net profit margin improved to approximately 2.23% in 2025. EBIT and EBITDA margins have been consistent, contributing to overall profitability. The company's ability to grow revenue consistently highlights its strong market position and effective business strategy.

Balance Sheet

The balance sheet of Ship Healthcare Holdings shows a healthy equity position, with a debt-to-equity ratio improving from 0.61 in 2020 to 0.25 in 2025, indicating reduced leverage and risk. The equity ratio remains strong, reflecting financial stability. Return on equity has improved, suggesting efficient use of shareholder funds. However, the reduction in cash reserves over time and the presence of debt warrants ongoing monitoring.

Cash Flow

Operating cash flow remains strong, supporting the company's operational needs. Despite fluctuations, free cash flow has shown positive growth, with a notable increase from 8.96 billion yen in 2022 to 16.56 billion yen in 2025. The operating cash flow to net income ratio is favorable, indicating effective cash management. While capital expenditures are well-managed, continuous monitoring of financing activities is recommended.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	686.32B	678.23B	630.99B	572.28B	514.35B	497.16B
Gross Profit	66.79B	66.74B	65.61B	60.62B	53.64B	54.49B
EBITDA	30.68B	32.19B	29.75B	28.61B	26.57B	26.69B
Net Income	14.09B	15.13B	13.79B	12.06B	12.17B	12.28B
Balance Sheet
Total Assets	367.17B	381.70B	386.82B	381.98B	335.07B	334.50B
Cash, Cash Equivalents and Short-Term Investments	80.57B	77.50B	85.07B	80.84B	73.81B	73.91B
Total Debt	31.56B	37.34B	57.93B	73.94B	61.22B	64.96B
Total Liabilities	220.75B	231.42B	244.60B	250.86B	212.76B	219.40B
Stockholders Equity	145.32B	149.08B	139.52B	128.04B	118.29B	111.44B
Cash Flow
Free Cash Flow	0.00	16.56B	28.09B	10.20B	8.96B	14.76B
Operating Cash Flow	0.00	20.38B	31.61B	14.11B	12.43B	19.77B
Investing Cash Flow	0.00	-4.03B	-7.20B	-6.77B	-3.87B	-19.29B
Financing Cash Flow	0.00	-24.62B	-20.48B	-1.02B	-8.84B	-10.46B

Ship Healthcare Holdings Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 2670.50
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3360, the sentiment is Neutral. The current price of 2670.5 is above the 20-day moving average (MA) of 2663.78, above the 50-day MA of 2626.64, and above the 200-day MA of 2256.94, indicating a neutral trend. The MACD of -4.64 indicates Positive momentum. The RSI at 34.29 is Neutral, neither overbought nor oversold. The STOCH value of 16.56 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:3360.

Ship Healthcare Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7817	76 Outperform	¥189.51B	21.67	6.47%	3.16%	1.96%	22.78%
3360	75 Outperform	¥221.62B	15.95	10.19%	2.19%	8.90%	-3.71%
7730	71 Outperform	¥149.95B	30.34	―	2.73%	5.10%	-26.13%
7716	66 Neutral	¥182.50B	27.08	5.66%	2.66%	5.43%	-20.67%
8086	62 Neutral	¥231.60B	21.27	4.38%	2.03%	6.04%	733.13%
3593	55 Neutral	¥144.24B	649.74	0.78%	1.31%	-2.06%	-79.17%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Ship Healthcare Holdings Corporate Events

Ship Healthcare Holdings Reports 7.5% Increase in Net Sales for H1 2025

Ship Healthcare Holdings reported its consolidated financial results for the six months ended September 30, 2025, with net sales increasing by 7.5% year-on-year to ¥333,385 million. Despite the growth in sales, the profit attributable to owners of the parent decreased by 1.9% to ¥5,432 million. The company also noted significant changes in the scope of consolidation, with the inclusion of three new companies and the elimination of nine. The forecast for the fiscal year ending March 31, 2026, anticipates a 3.2% increase in net sales to ¥700,000 million.

The most recent analyst rating on (JP:3360) stock is a Buy with a Yen2213.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.